| Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy MT May, M Gompels, V Delpech, K Porter, C Orkin, S Kegg, P Hay, ... Aids 28 (8), 1193-1202, 2014 | 702 | 2014 |
| Changes in the risk of death after HIV seroconversion compared with mortality in the general population K Bhaskaran, O Hamouda, M Sannes, F Boufassa, AM Johnson, ... Jama 300 (1), 51-59, 2008 | 677 | 2008 |
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study M May, M Gompels, V Delpech, K Porter, F Post, M Johnson, D Dunn, ... Bmj 343, 2011 | 476 | 2011 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 470 | 2011 |
| Beyond viral suppression of HIV–the new quality of life frontier JV Lazarus, K Safreed-Harmon, SE Barton, D Costagliola, N Dedes, ... BMC medicine 14, 1-5, 2016 | 371 | 2016 |
| Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy B Marin, R Thiébaut, HC Bucher, V Rondeau, D Costagliola, M Dorrucci, ... Aids 23 (13), 1743-1753, 2009 | 326 | 2009 |
| Response to combination antiretroviral therapy: variation by age Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Aids 22 (12), 1463-1473, 2008 | 272 | 2008 |
| Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy K Bhaskaran, C Mussini, A Antinori, AS Walker, M Dorrucci, C Sabin, ... Annals of neurology 63 (2), 213-221, 2008 | 269 | 2008 |
| Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need … S Lodi, A Phillips, G Touloumi, R Geskus, L Meyer, R Thiébaut, ... Clinical infectious diseases 53 (8), 817-825, 2011 | 261 | 2011 |
| Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study UK Group on Transmitted HIV Drug Resistance Bmj 331 (7529), 1368, 2005 | 223 | 2005 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 194 | 2014 |
| The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007 JJ van der Helm, M Prins, J del Amo, HC Bucher, G Chêne, M Dorrucci, ... Aids 25 (8), 1083-1091, 2011 | 175 | 2011 |
| Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or body fluids from patients infected with HIV. M McEvoy, K Porter, P Mortimer, N Simmons, D Shanson Br Med J (Clin Res Ed) 294 (6587), 1595-1597, 1987 | 164 | 1987 |
| Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion S Lodi, M Guiguet, D Costagliola, M Fisher, A De Luca, K Porter, ... Journal of the National Cancer Institute 102 (11), 784-792, 2010 | 157 | 2010 |
| Timing of HAART initiation and clinical outcomes among HIV-1 seroconverters MJ Funk, JS Fusco, SR Cole, JC Thomas, K Porter, JS Kaufman, ... Archives of internal medicine 171 (17), 1560, 2011 | 152 | 2011 |
| Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS … A Babiker, S Darby, D De Angelis, D Kwart, K Porter, V Beral, ... Lancet 355 (9210), 2000 | 148 | 2000 |
| Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts G Touloumi, N Pantazis, D Pillay, D Paraskevis, ML Chaix, HC Bucher, ... Clinical infectious diseases 56 (6), 888-897, 2013 | 134 | 2013 |
| Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion S Lodi, L Meyer, AD Kelleher, M Rosinska, J Ghosn, M Sannes, K Porter Archives of internal medicine 172 (16), 1252-1255, 2012 | 129 | 2012 |
| HIV‐associated central nervous system diseases in the recent combination antiretroviral therapy era UK Collaborative HIV Cohort (CHIC) Study Steering Committee European journal of neurology 18 (3), 527-534, 2011 | 126 | 2011 |
| Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women I Jarrin, R Geskus, K Bhaskaran, M Prins, S Perez-Hoyos, R Muga, ... American journal of epidemiology 168 (5), 532-540, 2008 | 126 | 2008 |
Caroline SabinProfessor of Medical Statistics and Epidemiology, UCLVerified email at ucl.ac.uk
